title: Sildenafil citrate (VIAGRA): overall safety profile in 18 double-blind, placebo controlled, clinical trials.
authors.affiliation: Pfizer Central Research, Sandwich, Kent, UK.
authors.forename: I H
authors.initials: IH
authors.lastname: Osterloh
authors.forename: M
authors.initials: M
authors.lastname: Collins
authors.forename: P
authors.initials: P
authors.lastname: Wicker
authors.forename: G
authors.initials: G
authors.lastname: Wagner
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D018849:Controlled Clinical Trials as Topic; D004311:Double-Blind Method; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones
chemical_list: D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate